Recruiting Bladder Cancer Studies in Fairbanks
Intravesical BCG vs GEMDOCE in NMIBC
The study hypothesis is that BCG naïve non-muscle invasive bladder cancer (NMIBC) patients treated with intravesical Gemcitabine + Docetaxel (GEMDOCE) will result in a non-inferior event-free survival...
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations
This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydr...
About Bladder Cancer Clinical Trials in Fairbanks
Bladder cancer occurs in the tissues of the bladder and is one of the most common cancers. It has a high recurrence rate, requiring ongoing monitoring. Treatments include surgery, intravesical therapy, chemotherapy, and immunotherapy.
There are currently 2 bladder cancer clinical trials recruiting participants in Fairbanks, ALASKA. These studies are seeking a combined 1,141 participants. Research is being sponsored by ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology. Clinical trial participation is free and participants receive study-related medical care at no cost.
Bladder Cancer Clinical Trials in Fairbanks — FAQ
Are there bladder cancer clinical trials in Fairbanks?
Yes, there are 2 bladder cancer clinical trials currently recruiting in Fairbanks, ALASKA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Fairbanks?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fairbanks research site will contact you about next steps.
Are clinical trials in Fairbanks free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fairbanks studies also compensate for your time and travel.
What bladder cancer treatments are being tested?
The 2 active trials in Fairbanks are testing new therapies including novel drugs, biologics, and treatment approaches for bladder cancer.
Data updated March 2, 2026 from ClinicalTrials.gov